Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis
Clinical trial NCT03221036 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03221036
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-03
- Primary completion
- 2027-09-24
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.